<DOC>
	<DOCNO>NCT02386982</DOCNO>
	<brief_summary>This study evaluate beta cell function , pharmacodynamics , pharmacokinetics , safety tolerability 4 week treatment 75mgBID 75mgQD HMS5552 .</brief_summary>
	<brief_title>Beta Cell Function Related Pharmacodynamics HMS5552 T2DM Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female , age 1865 year Has type 2 diabetes mellitus BMI 20 29kg/m2 Willingness adhere protocol requirement Patients type1 diabetes mellitus Received antidiabetic drug within runin screen Hepatic disease Kidney diseases Clinical abnormal find EVG , labs physical exam Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>